APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Monogenic Disease Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Monogenic Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174192950316 January 2026186 pages

Choose your research edition.

Industry ResearchMonogenic Disease Testing Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Monogenic Disease Testing Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Monogenic Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Monogenic Disease Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Monogenic Disease Testing Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Monogenic Disease Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Monogenic Disease Testing include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Monogenic Disease Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Monogenic Disease Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Monogenic Disease Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Monogenic Disease Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Monogenic Disease Testing Segment by Company

Celera Support Services

Abbott

ELITech Group

Auto Genomics

PerkinElmer

Bio-Rad Laboratories

Monogenic Disease Testing Segment by Type

Carrier Testing

Diagnostic Testing

New-Born Screening

Predictive and Pre-Symptomatic Testing

Prenatal Testing

Monogenic Disease Testing Segment by Application

Hospitals

Clinics

Others

Monogenic Disease Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monogenic Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Monogenic Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monogenic Disease Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Monogenic Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Monogenic Disease Testing industry.

Chapter 3: Detailed analysis of Monogenic Disease Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Monogenic Disease Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Monogenic Disease Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Carrier Testing Table 3. Key Players of Diagnostic Testing Table 4. Key Players of New-Born Screening Table 3. Key Players of Predictive and Pre-Symptomatic Testing Table 4. Key Players of Prenatal Testing Table 5. Global Monogenic Disease Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Clinics Table 8. Key Players of Others Table 9. Global Monogenic Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Monogenic Disease Testing Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Monogenic Disease Testing Market Share by Region (2021-2026) Table 12. Global Monogenic Disease Testing Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Monogenic Disease Testing Market Share by Region (2027-2032) Table 14. Monogenic Disease Testing Industry Trends Table 15. Monogenic Disease Testing Industry Drivers Table 16. Monogenic Disease Testing Industry Opportunities and Challenges Table 17. Monogenic Disease Testing Industry Restraints Table 18. Global Monogenic Disease Testing Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Monogenic Disease Testing Revenue Market Share by Company (2021-2026) Table 20. Global Monogenic Disease Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Monogenic Disease Testing Key Company Head Office and Area Served Table 22. Global Monogenic Disease Testing Company, Product Type & Application Table 23. Global Monogenic Disease Testing Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Monogenic Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Monogenic Disease Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Monogenic Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Monogenic Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Monogenic Disease Testing Revenue Market Share by Type (2021-2026) Table 30. Global Monogenic Disease Testing Revenue Market Share by Type (2027-2032) Table 31. Global Monogenic Disease Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Monogenic Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Monogenic Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Monogenic Disease Testing Revenue Market Share by Application (2021-2026) Table 35. Global Monogenic Disease Testing Revenue Market Share by Application (2027-2032) Table 36. Celera Support Services Company Information Table 37. Celera Support Services Business Overview Table 38. Celera Support Services Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Celera Support Services Monogenic Disease Testing Product Portfolio Table 40. Celera Support Services Recent Development Table 41. Abbott Company Information Table 42. Abbott Business Overview Table 43. Abbott Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Abbott Monogenic Disease Testing Product Portfolio Table 45. Abbott Recent Development Table 46. ELITech Group Company Information Table 47. ELITech Group Business Overview Table 48. ELITech Group Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ELITech Group Monogenic Disease Testing Product Portfolio Table 50. ELITech Group Recent Development Table 51. Auto Genomics Company Information Table 52. Auto Genomics Business Overview Table 53. Auto Genomics Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Auto Genomics Monogenic Disease Testing Product Portfolio Table 55. Auto Genomics Recent Development Table 56. PerkinElmer Company Information Table 57. PerkinElmer Business Overview Table 58. PerkinElmer Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. PerkinElmer Monogenic Disease Testing Product Portfolio Table 60. PerkinElmer Recent Development Table 61. Bio-Rad Laboratories Company Information Table 62. Bio-Rad Laboratories Business Overview Table 63. Bio-Rad Laboratories Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bio-Rad Laboratories Monogenic Disease Testing Product Portfolio Table 65. Bio-Rad Laboratories Recent Development Table 66. North America Monogenic Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 67. North America Monogenic Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 68. North America Monogenic Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 69. North America Monogenic Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 70. North America Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. North America Monogenic Disease Testing Market Size by Country (2021-2026) Table 72. North America Monogenic Disease Testing Market Size by Country (2027-2032) Table 73. Europe Monogenic Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 74. Europe Monogenic Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 75. Europe Monogenic Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 76. Europe Monogenic Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 77. Europe Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Europe Monogenic Disease Testing Market Size by Country (2021-2026) Table 79. Europe Monogenic Disease Testing Market Size by Country (2027-2032) Table 80. China Monogenic Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 81. China Monogenic Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 82. China Monogenic Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 83. China Monogenic Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 84. Asia Monogenic Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 85. Asia Monogenic Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 86. Asia Monogenic Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 87. Asia Monogenic Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Asia Monogenic Disease Testing Market Size by Country (2021-2026) Table 90. Asia Monogenic Disease Testing Market Size by Country (2027-2032) Table 91. South America, Middle East & Africa Monogenic Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa Monogenic Disease Testing Market Size by Type (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa Monogenic Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 94. South America, Middle East & Africa Monogenic Disease Testing Market Size by Application (2027-2032) & (US$ Million) Table 95. South America, Middle East & Africa Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. South America, Middle East & Africa Monogenic Disease Testing Market Size by Country (2021-2026) Table 97. South America, Middle East & Africa Monogenic Disease Testing Market Size by Country (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Monogenic Disease Testing Product Image Figure 2. Global Monogenic Disease Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Monogenic Disease Testing Market Share by Type: 2025 VS 2032 Figure 4. Carrier Testing Image Figure 5. Diagnostic Testing Image Figure 6. New-Born Screening Image Figure 7. Predictive and Pre-Symptomatic Testing Image Figure 8. Prenatal Testing Image Figure 9. Global Monogenic Disease Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Monogenic Disease Testing Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Others Image Figure 14. Global Monogenic Disease Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 16. Global Monogenic Disease Testing Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Monogenic Disease Testing Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Monogenic Disease Testing Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Monogenic Disease Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Monogenic Disease Testing Revenue Market Share by Type (2021-2032) Figure 23. Global Monogenic Disease Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Monogenic Disease Testing Revenue Market Share by Application (2021-2032) Figure 25. North America Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 26. North America Monogenic Disease Testing Market Share by Type (2021-2032) Figure 27. North America Monogenic Disease Testing Market Share by Application (2021-2032) Figure 28. North America Monogenic Disease Testing Market Share by Country (2021-2032) Figure 29. United States Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 30. Canada Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 32. Europe Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 33. Europe Monogenic Disease Testing Market Share by Type (2021-2032) Figure 34. Europe Monogenic Disease Testing Market Share by Application (2021-2032) Figure 35. Europe Monogenic Disease Testing Market Share by Country (2021-2032) Figure 36. Germany Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 37. France Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 39. Italy Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 40. Russia Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 42. China Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 43. China Monogenic Disease Testing Market Share by Type (2021-2032) Figure 44. China Monogenic Disease Testing Market Share by Application (2021-2032) Figure 45. Asia Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 46. Asia Monogenic Disease Testing Market Share by Type (2021-2032) Figure 47. Asia Monogenic Disease Testing Market Share by Application (2021-2032) Figure 48. Asia Monogenic Disease Testing Market Share by Country (2021-2032) Figure 49. Japan Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 53. India Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 54. Australia Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Monogenic Disease Testing Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Monogenic Disease Testing Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Monogenic Disease Testing Market Share by Country (2021-2032) Figure 59. Brazil Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 64. UAE Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 66. Chile Monogenic Disease Testing Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Carrier Testing
  • Diagnostic Testing
  • New-Born Screening
  • Predictive and Pre-Symptomatic Testing
  • Prenatal Testing
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Celera Support Services
  • Abbott
  • ELITech Group
  • Auto Genomics
  • PerkinElmer
  • Bio-Rad Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Monogenic Disease Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Carrier Testing
  5. 1.2.3 Diagnostic Testing
  6. 1.2.4 New-Born Screening
  7. 1.2.5 Predictive and Pre-Symptomatic Testing
  8. 1.2.6 Prenatal Testing
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Monogenic Disease Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Monogenic Disease Testing Growth Trends by Region
  16. 1.5.1 Global Monogenic Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Monogenic Disease Testing Market Size by Region (2021-2026)
  18. 1.5.3 Monogenic Disease Testing Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Monogenic Disease Testing Market Dynamics
  1. 2.1 Monogenic Disease Testing Industry Trends
  2. 2.2 Monogenic Disease Testing Industry Drivers
  3. 2.3 Monogenic Disease Testing Industry Opportunities and Challenges
  4. 2.4 Monogenic Disease Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Monogenic Disease Testing Revenue by Company (2021-2026)
  2. 3.2 Global Monogenic Disease Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Monogenic Disease Testing Key Company Head office and Area Served
  4. 3.4 Global Monogenic Disease Testing Company, Product Type & Application
  5. 3.5 Global Monogenic Disease Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Monogenic Disease Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Monogenic Disease Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Monogenic Disease Testing Tier 1, Tier 2, and Tier 3
4 Monogenic Disease Testing Market by Type
  1. 4.1 Global Monogenic Disease Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Monogenic Disease Testing Market Size by Type (2021-2032)
  3. 4.3 Global Monogenic Disease Testing Market Size Share by Type (2021-2032)
5 Monogenic Disease Testing Market by Application
  1. 5.1 Global Monogenic Disease Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Monogenic Disease Testing Market Size by Application (2021-2032)
  3. 5.3 Global Monogenic Disease Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Celera Support Services
  2. 6.1.1 Celera Support Services Company Information
  3. 6.1.2 Celera Support Services Business Overview
  4. 6.1.3 Celera Support Services Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Celera Support Services Monogenic Disease Testing Product Portfolio
  6. 6.1.5 Celera Support Services Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott Monogenic Disease Testing Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 ELITech Group
  14. 6.3.1 ELITech Group Company Information
  15. 6.3.2 ELITech Group Business Overview
  16. 6.3.3 ELITech Group Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ELITech Group Monogenic Disease Testing Product Portfolio
  18. 6.3.5 ELITech Group Recent Developments
  19. 6.4 Auto Genomics
  20. 6.4.1 Auto Genomics Company Information
  21. 6.4.2 Auto Genomics Business Overview
  22. 6.4.3 Auto Genomics Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Auto Genomics Monogenic Disease Testing Product Portfolio
  24. 6.4.5 Auto Genomics Recent Developments
  25. 6.5 PerkinElmer
  26. 6.5.1 PerkinElmer Company Information
  27. 6.5.2 PerkinElmer Business Overview
  28. 6.5.3 PerkinElmer Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 PerkinElmer Monogenic Disease Testing Product Portfolio
  30. 6.5.5 PerkinElmer Recent Developments
  31. 6.6 Bio-Rad Laboratories
  32. 6.6.1 Bio-Rad Laboratories Company Information
  33. 6.6.2 Bio-Rad Laboratories Business Overview
  34. 6.6.3 Bio-Rad Laboratories Monogenic Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories Monogenic Disease Testing Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories Recent Developments
7 North America
  1. 7.1 North America Monogenic Disease Testing Market Size (2021-2032)
  2. 7.2 North America Monogenic Disease Testing Market Size by Type
  3. 7.2.1 North America Monogenic Disease Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Monogenic Disease Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Monogenic Disease Testing Market Share by Type (2021-2032)
  6. 7.3 North America Monogenic Disease Testing Market Size by Application
  7. 7.3.1 North America Monogenic Disease Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Monogenic Disease Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Monogenic Disease Testing Market Share by Application (2021-2032)
  10. 7.4 North America Monogenic Disease Testing Market Size by Country
  11. 7.4.1 North America Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Monogenic Disease Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Monogenic Disease Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Monogenic Disease Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Monogenic Disease Testing Market Size (2021-2032)
  2. 8.2 Europe Monogenic Disease Testing Market Size by Type
  3. 8.2.1 Europe Monogenic Disease Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Monogenic Disease Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Monogenic Disease Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Monogenic Disease Testing Market Size by Application
  7. 8.3.1 Europe Monogenic Disease Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Monogenic Disease Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Monogenic Disease Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Monogenic Disease Testing Market Size by Country
  11. 8.4.1 Europe Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Monogenic Disease Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Monogenic Disease Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Monogenic Disease Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Monogenic Disease Testing Market Size (2021-2032)
  2. 9.2 China Monogenic Disease Testing Market Size by Type
  3. 9.2.1 China Monogenic Disease Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Monogenic Disease Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Monogenic Disease Testing Market Share by Type (2021-2032)
  6. 9.3 China Monogenic Disease Testing Market Size by Application
  7. 9.3.1 China Monogenic Disease Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Monogenic Disease Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Monogenic Disease Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Monogenic Disease Testing Market Size (2021-2032)
  2. 10.2 Asia Monogenic Disease Testing Market Size by Type
  3. 10.2.1 Asia Monogenic Disease Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Monogenic Disease Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Monogenic Disease Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Monogenic Disease Testing Market Size by Application
  7. 10.3.1 Asia Monogenic Disease Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Monogenic Disease Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Monogenic Disease Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Monogenic Disease Testing Market Size by Country
  11. 10.4.1 Asia Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Monogenic Disease Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Monogenic Disease Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Monogenic Disease Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Monogenic Disease Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Monogenic Disease Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Monogenic Disease Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Monogenic Disease Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Monogenic Disease Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Monogenic Disease Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Monogenic Disease Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Monogenic Disease Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Monogenic Disease Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Monogenic Disease Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Monogenic Disease Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Monogenic Disease Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Monogenic Disease Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Monogenic Disease Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst